Target Name: HIP1
NCBI ID: G3092
Review Report on HIP1 Target / Biomarker Content of Review Report on HIP1 Target / Biomarker
HIP1
Other Name(s): Huntingtin-interacting protein I | HIP1_HUMAN | HIP1 variant 1 | Huntingtin-interacting protein 1 | Huntingtin interacting protein 1, transcript variant 1 | huntingtin-interacting protein I | SHONbeta | HIP1 variant 2 | SHONgamma | SHON | ILWEQ | HIP-1 | huntingtin interacting protein 1 | Huntingtin-interacting protein 1 (isoform 1) | Huntingtin-interacting protein 1 (isoform 2) | HIP-I | Huntingtin interacting protein 1, transcript variant 2

HIP1: A Drug Target / Disease Biomarker

HIP1, also known as heat shock protein 1, is a protein that is expressed in high levels in the cells under stress, such as cells under the influence of ionizing radiation or other forms of stress. It is a member of the heat shock protein (HSP) family, which includes a variety of proteins that are expressed in response to stress and are involved in the regulation of cellular stress responses.

HIP1 is a protein that is expressed in many different tissues and cells in the body, including muscle cells, nerve cells, and cells of the immune system. It is also expressed in various organs and tissues, including the heart, lungs, and kidneys. HIP1 is involved in a variety of cellular processes that are critical for maintaining cellular health and homeostasis.

One of the key functions of HIP1 is its role in the regulation of cellular stress responses. When cells are exposed to stressors, such as ionizing radiation or other forms of stress, HIP1 helps to coordinate the cellular stress response by regulating the production and distribution of other proteins involved in the stress response. This allows cells to respond to stress in a controlled and efficient manner, minimizing the damage caused by the stressor and maintaining cellular health.

Another important function of HIP1 is its role in the regulation of cellular signaling pathways. HIP1 is involved in a variety of signaling pathways that are critical for maintaining cellular function and homeostasis. For example, HIP1 is involved in the regulation of the production and activity of other proteins involved in the Wnt signaling pathway, a pathway that is involved in the development and maintenance of tissues and organs.

In addition to its role in cellular stress responses and signaling pathways, HIP1 is also involved in the regulation of cellular adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and HIP1 is involved in the regulation of the stickiness of cells to their neighbors. This is important for the development and maintenance of tissues and organs, and is also involved in the regulation of various diseases, such as cancer.

HIP1 is also involved in the regulation of cellular angiogenesis, the process by which new blood vessels are formed in response to increased blood flow to a particular area. This is important for the development and maintenance of tissues and organs, and is also involved in the regulation of various diseases, such as heart disease and diabetes.

In conclusion, HIP1 is a protein that is involved in a variety of cellular processes that are critical for maintaining cellular health and homeostasis. Its role in the regulation of cellular stress responses, signaling pathways, adhesion, and angiogenesis makes it an attractive drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the mechanisms of HIP1 and its role in cellular biology, and to develop effective treatments for the prevention and treatment of diseases associated with HIP1 dysfunction.

Protein Name: Huntingtin Interacting Protein 1

Functions: Plays a role in clathrin-mediated endocytosis and trafficking (PubMed:11532990, PubMed:11577110, PubMed:11889126). Involved in regulating AMPA receptor trafficking in the central nervous system in an NMDA-dependent manner (By similarity). Regulates presynaptic nerve terminal activity (By similarity). Enhances androgen receptor (AR)-mediated transcription (PubMed:16027218). May act as a proapoptotic protein that induces cell death by acting through the intrinsic apoptosis pathway (PubMed:11007801). Binds 3-phosphoinositides (via ENTH domain) (PubMed:14732715). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis (PubMed:14732715). May play a functional role in the cell filament networks (PubMed:18790740). May be required for differentiation, proliferation, and/or survival of somatic and germline progenitors (PubMed:11007801, PubMed:12163454)

The "HIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HIP1R | HIPK1 | HIPK1-AS1 | HIPK2 | HIPK3 | HIPK4 | HIRA | HIRIP3 | HISLA | Histamine Receptor (HR) | Histocompatibility antigen-related | Histone | Histone acetyltransferase (HAT) | Histone deacetylase | Histone H2A | Histone H2B | Histone H3 | Histone Lysine Demethylase | Histone methyltransferase | HIVEP1 | HIVEP2 | HIVEP3 | HJURP | HJV | HK1 | HK2 | HK2P1 | HK3 | HKDC1 | HLA Class II Histocompatibility Antigen DM (HLA-DM) | HLA class II histocompatibility Antigen DO (HLA-DO) | HLA class II histocompatibility antigen DP (HLA-DP) | HLA Class II Histocompatibility Antigen DQ8 | HLA class II histocompatibility antigen DR (HLA-DR) | HLA Class II Histocompatibility Antigen, DQ (HLA-DQ) | HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 | HLA complex group 16 (non-protein coding), transcript variant X2 | HLA complex group 8 | HLA-A | HLA-B | HLA-C | HLA-DMA | HLA-DMB | HLA-DOA | HLA-DOB | HLA-DPA1 | HLA-DPA2 | HLA-DPA3 | HLA-DPB1 | HLA-DPB2 | HLA-DQA1 | HLA-DQA2 | HLA-DQB1 | HLA-DQB1-AS1 | HLA-DQB2 | HLA-DRA | HLA-DRB1 | HLA-DRB2 | HLA-DRB3 | HLA-DRB4 | HLA-DRB5 | HLA-DRB6 | HLA-DRB7 | HLA-DRB8 | HLA-DRB9 | HLA-E | HLA-F | HLA-F-AS1 | HLA-G | HLA-H | HLA-J | HLA-K | HLA-L | HLA-N | HLA-P | HLA-U | HLA-V | HLA-W | HLCS | HLF | HLTF | HLX | HM13 | HMBOX1 | HMBS | HMCES | HMCN1 | HMCN2 | HMG20A | HMG20B | HMGA1 | HMGA1P2 | HMGA1P4 | HMGA1P7 | HMGA1P8 | HMGA2 | HMGA2-AS1 | HMGB1 | HMGB1P1 | HMGB1P10